7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication

Inclusion Criteria: 1. Participants in the age group (10-18 years), both genders, referred with dyspeptic complaints such as heartburn, dyspepsia, nausea, and epigastric pain who are positive for H. Pylori infection by a standardized diagnostic test. 2. Pediatric patients with a clinical, laboratory, and endoscopic diagnosis of H.P.-positive gastritis and the other conditions necessary for H.P. eradication, according to the Maastricht V consensus report . Exclusion Criteria: 1. allergy to any of the drugs used in the study 2. previous attempts to eradicate H.P. 3. receipt of antibiotics, PPIs, bismuth, H2 antagonists or probiotics within 4 weeks of the study. 4. Children with the diagnosis of any condition that might affect the absorption of drugs such as celiac disease or Crohn's disease. 5. hepatic impairment or kidney failure. 6. symptoms suggestive of functional disorders.